Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 8, Pages 2621-2627Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm051250z
Keywords
-
Categories
Ask authors/readers for more resources
In this study we report the design, synthesis, and activity against bovine viral diarrhea virus (BVDV) of a novel series of acridone derivatives. BVDV is responsible for major losses in cattle. The virus is also considered to be a valuable surrogate for the hepatitis C virus (HCV) in antiviral drug studies. Some of the synthesized acridones elicited selective anti-BVDV activity with EC50 values ranging from 0.4 to 4 mu g/mL and were not cytotoxic at concentrations that were 25- to 200-fold higher (CC50 > 100 mu g/mL). It was proven that the most potent acridone derivative 10 was able to not only protect cells from virus-induced cytopathic effect but also reduce the production of infectious virus and extracellular viral RNA. Furthermore, compound 10, as well as a number of other analogues, inhibited HCV replication to some extent. However, there was no direct correlation between anti-BVDV and anti-HCV activity. Thus, the acridone scaffold, when appropriately functionalized, can yield compounds with selective activity against pestiviruses and related viruses such as the HCV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available